Tell me moa clinical uses and adverse effect and contra indications

Reading File

Finding Sources

Reading File

I have enough foundational information. Now I'll compile a comprehensive answer for all 6 drugs from the prescription.

Prescription Drug Review

The prescription contains 6 drugs. Here is the MOA, clinical uses, adverse effects, and contraindications for each:

1. 🟦 FEXET 120 mg (Fexofenadine) — PO OD

Mechanism of Action

Selective, peripheral H1-receptor antagonist (second-generation antihistamine). It does NOT cross the blood-brain barrier significantly, hence minimal sedation. It is a metabolite of terfenadine.

Clinical Uses

Seasonal allergic rhinitis (hay fever)
Chronic idiopathic urticaria (hives)
Allergic conjunctivitis
Pruritus (itching) — in combination with montelukast

Adverse Effects

Headache, dizziness (mild)
Nausea, dyspepsia
Fatigue (less than older antihistamines)
No significant CNS sedation (major advantage)

Contraindications

Hypersensitivity to fexofenadine
Drug interaction: Avoid with grapefruit juice (inhibits OATP transporters → reduced drug absorption)
Use with caution in renal impairment (dose reduction needed)

2. 🟧 HY-CORTISONE 100 mg IV TDS (Hydrocortisone / Cortisol)

Mechanism of Action

Glucocorticoid (and mild mineralocorticoid). Binds intracellular glucocorticoid receptors → alters gene transcription → suppresses inflammatory cytokines (IL-1, IL-6, TNF-α), stabilizes mast cells, inhibits phospholipase A2 (reducing prostaglandin/leukotriene synthesis).

Clinical Uses

Acute allergic reactions and anaphylaxis (IV)
Acute severe asthma / status asthmaticus
Adrenal insufficiency / Addisonian crisis
Inflammatory conditions (IBD, autoimmune disease)
Shock (septic, anaphylactic)
Congenital adrenal hyperplasia (replacement)

Adverse Effects

With short-term IV use (as prescribed here, TDS): generally well tolerated. With prolonged use:

Hyperglycemia, HPA axis suppression
Hypertension, fluid/sodium retention (mineralocorticoid effect)
Immunosuppression (opportunistic infections)
Osteoporosis, peptic ulcer
Cushing's syndrome (cushingoid features)
Psychiatric effects (mood changes, insomnia)

Contraindications

Active untreated infections (relative CI)
Live vaccines during therapy
Systemic fungal infections (absolute)
Peptic ulcer disease (relative)

3. 🟩 EUROCAP NS 100 mL (Normal Saline — IV Fluid)

This is simply 0.9% Sodium Chloride — used as a IV vehicle/diluent for hydrocortisone and as maintenance fluid. No pharmacological MOA. CI: hypernatremia, fluid overload states.

4. 🟥 OXIDIL 2 GM IV OD (Oxacillin — Beta-lactam Antibiotic)

(OXIDIL is a brand name for Oxacillin in several countries)

Mechanism of Action

Beta-lactam antibiotic (penicillinase-resistant penicillin). Inhibits bacterial cell wall synthesis by binding to Penicillin Binding Proteins (PBPs), preventing peptidoglycan cross-linking → cell lysis. Resistant to staphylococcal beta-lactamase.

Clinical Uses

Staphylococcal infections (MSSA — methicillin-sensitive S. aureus)
Cellulitis, skin and soft tissue infections
Septicemia, osteomyelitis, endocarditis due to MSSA
Post-operative wound infections

Adverse Effects

Hypersensitivity reactions (urticaria, rash, anaphylaxis)
GI: nausea, diarrhea
Hepatotoxicity (elevated liver enzymes — monitor LFTs)
Neutropenia, thrombocytopenia (with prolonged use)
Interstitial nephritis (rare)

Contraindications

Penicillin allergy / hypersensitivity
MRSA infections (oxacillin is ineffective against MRSA)

5. 🟪 SCIMONT 10 mg (Montelukast — Leukotriene Receptor Antagonist)

Mechanism of Action

Selectively blocks cysteinyl leukotriene type 1 (CysLT1) receptors — blocks the action of leukotrienes (LTD4, LTC4, LTE4), which are potent bronchoconstrictors and pro-inflammatory mediators released by mast cells and eosinophils.

Clinical Uses

Bronchial asthma — prophylaxis and maintenance (especially in children)
Allergic rhinitis (seasonal and perennial)
Exercise-induced bronchoconstriction prophylaxis
Aspirin-induced asthma (particularly effective)
Chronic urticaria (in combination with antihistamines)

Adverse Effects

Headache
GI disturbances (abdominal pain, nausea)
Neuropsychiatric effects (FDA black box warning): mood changes, depression, suicidal ideation, nightmares — especially in pediatric patients
Elevated liver enzymes (rare)
Churg-Strauss syndrome (rare, with steroid tapering)

Contraindications

Hypersensitivity to montelukast
Not for acute bronchospasm (not a bronchodilator)
History of neuropsychiatric illness (relative CI)
Phenylketonuria (if chewable tablets containing phenylalanine)

6. 🔵 AVELON 400 mg PO OD (Moxifloxacin — Fluoroquinolone)

Mechanism of Action

4th-generation fluoroquinolone. Inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV → prevents DNA replication, transcription, and repair → bactericidal. Excellent coverage: Gram-positive (including S. pneumoniae), Gram-negative, atypicals (Mycoplasma, Chlamydia, Legionella), and anaerobes.

Clinical Uses

Community-acquired pneumonia (CAP) — first-line
Acute bacterial exacerbation of chronic bronchitis (ABECB)
Sinusitis, skin and soft tissue infections
Intra-abdominal infections (due to anaerobic coverage)
Tuberculosis (second-line)
NOT for UTIs (does not achieve adequate urinary concentrations)

Adverse Effects

QTc prolongation (risk of torsades de pointes — serious)
GI: nausea, diarrhea, abdominal pain
CNS: dizziness, headache, insomnia
Tendinopathy / tendon rupture (especially Achilles — increased risk in elderly and steroid users)
Peripheral neuropathy
Photosensitivity
Hepatotoxicity

Contraindications

QT prolongation or concurrent use of QT-prolonging drugs
Patients on Class IA or III antiarrhythmics
Myasthenia gravis (may worsen neuromuscular blockade)
Hypersensitivity to fluoroquinolones
Pregnancy and children (cartilage damage risk)
Avoid in patients already on corticosteroids (↑ tendon rupture risk — note: this patient IS on hydrocortisone; monitor)

7. 🔴 COMBIHALE NEBULES QID (Budesonide + Formoterol)

Mechanism of Action

Combination of:

Budesonide (inhaled corticosteroid/ICS): binds glucocorticoid receptors → reduces airway inflammation, mucus production, bronchial hyperreactivity
Formoterol (long-acting beta-2 agonist/LABA): stimulates β2-adrenoceptors on bronchial smooth muscle → activates adenylyl cyclase → ↑ cAMP → bronchodilation (onset within 1–3 min, duration 12 h)

Clinical Uses

Moderate-to-severe asthma maintenance therapy
COPD — maintenance and exacerbation prevention
Acute asthma exacerbation (via nebulization, as prescribed QID)
Prevents exercise-induced bronchospasm

Adverse Effects

Budesonide (inhaled):

Oral candidiasis (thrush) — rinse mouth after use
Dysphonia (hoarse voice)
Mild HPA axis suppression at high doses

Formoterol (LABA):

Tachycardia, palpitations, tremor
Hypokalemia (especially with IV hydrocortisone — monitor K⁺ in this patient)
Hyperglycemia

Combined:

Paradoxical bronchospasm (rare)

Contraindications

Monotherapy with LABA (without ICS) in asthma (↑ asthma-related death risk)
Hypersensitivity to budesonide or formoterol
Acute severe bronchospasm requiring only short-acting bronchodilator (SABA is preferred for rescue)

⚠️ Important Clinical Notes for This Prescription

Interaction	Concern
Hydrocortisone IV + Formoterol	Both cause hypokalemia — monitor serum K⁺
Hydrocortisone + Moxifloxacin	Both may prolong QTc and corticosteroids increase tendon rupture risk with fluoroquinolones
Moxifloxacin	Avoid concurrent antacids/dairy within 4 hours (chelation reduces absorption)

This is a classic prescription for a patient with acute severe asthma or allergic bronchospasm with superimposed respiratory infection — combining anti-inflammatory, bronchodilator, antihistamine, leukotriene blocker, and antibiotic therapy.

This is a shared conversation. Sign in to Orris to start your own chat.